These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27521362)

  • 21. Vaccines for the prevention of human cytomegalovirus infection.
    Plotkin SA; Starr SE; Friedman HM; Gonczol E; Brayman K
    Rev Infect Dis; 1990; 12 Suppl 7():S827-38. PubMed ID: 2173112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial.
    Plotkin SA; Starr SE; Friedman HM; Brayman K; Harris S; Jackson S; Tustin NB; Grossman R; Dafoe D; Barker C
    Ann Intern Med; 1991 Apr; 114(7):525-31. PubMed ID: 1848053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB.
    Lilja AE; Mason PW
    Vaccine; 2012 Nov; 30(49):6980-90. PubMed ID: 23041121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection.
    Cui X; Meza BP; Adler SP; McVoy MA
    Vaccine; 2008 Oct; 26(45):5760-6. PubMed ID: 18718497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults.
    Bernstein DI; Schleiss MR; Berencsi K; Gonczol E; Dickey M; Khoury P; Cadoz M; Meric C; Zahradnik J; Duliege AM; Plotkin S
    J Infect Dis; 2002 Mar; 185(5):686-90. PubMed ID: 11865427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus vaccine: persistence of humoral immunity following immunization of renal transplant candidates.
    Sachs GW; Simmons RL; Balfour HH
    Vaccine; 1984 Sep; 2(3):215-8. PubMed ID: 6099649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of Cytomegalovirus Dense Bodies by Scalable Bioprocess Methods Maintains Immunogenicity and Improves Neutralizing Antibody Titers.
    Schneider-Ohrum K; Cayatte C; Liu Y; Wang Z; Irrinki A; Cataniag F; Nguyen N; Lambert S; Liu H; Aslam S; Duke G; McCarthy MP; McCormick L
    J Virol; 2016 Nov; 90(22):10133-10144. PubMed ID: 27581989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity.
    John S; Yuzhakov O; Woods A; Deterling J; Hassett K; Shaw CA; Ciaramella G
    Vaccine; 2018 Mar; 36(12):1689-1699. PubMed ID: 29456015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humoral immunity targeting site I of antigenic domain 2 of glycoprotein B upon immunization with different cytomegalovirus candidate vaccines.
    Axelsson F; Adler SP; Lamarre A; Ohlin M
    Vaccine; 2007 Dec; 26(1):41-6. PubMed ID: 18063447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The status of cytomegalovirus vaccine.
    Starr SE; Friedman HM; Plotkin SA
    Rev Infect Dis; 1991; 13 Suppl 11():S964-5. PubMed ID: 1664136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimized recombinant dense bodies of human cytomegalovirus efficiently prime virus specific lymphocytes and neutralizing antibodies without the addition of adjuvant.
    Becke S; Aue S; Thomas D; Schader S; Podlech J; Bopp T; Sedmak T; Wolfrum U; Plachter B; Reyda S
    Vaccine; 2010 Aug; 28(38):6191-8. PubMed ID: 20655401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease.
    Fu TM; An Z; Wang D
    Vaccine; 2014 May; 32(22):2525-33. PubMed ID: 24681264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Live Olfactory Mouse Cytomegalovirus Vaccine, Attenuated for Systemic Spread, Protects against Superinfection.
    Farrell HE; Bruce K; Stevenson PG
    J Virol; 2021 Oct; 95(21):e0126421. PubMed ID: 34431701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Original Antigenic Sin Shapes the Immunological Repertoire Evoked by Human Cytomegalovirus Glycoprotein B/MF59 Vaccine in Seropositive Recipients.
    Baraniak I; Kern F; Holenya P; Griffiths P; Reeves M
    J Infect Dis; 2019 Jun; 220(2):228-232. PubMed ID: 30815685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guinea pig and human cytomegaloviruses do not share cross-reactive neutralizing epitopes.
    Adler SP; Shaw KV; McVoy M; Burke RL; Liu H
    J Med Virol; 1995 Sep; 47(1):48-51. PubMed ID: 8551258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent Approaches and Strategies in the Generation of Anti-human Cytomegalovirus Vaccines.
    Boppana SB; Britt WJ
    Methods Mol Biol; 2021; 2244():403-463. PubMed ID: 33555597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination of pediatric nurses with live attenuated cytomegalovirus.
    Fleisher GR; Starr SE; Friedman HM; Plotkin SA
    Am J Dis Child; 1982 Apr; 136(4):294-6. PubMed ID: 6280490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants.
    Plotkin SA; Smiley ML; Friedman HM; Starr SE; Fleisher GR; Wlodaver C; Dafoe DC; Friedman AD; Grossman RA; Barker CF
    Lancet; 1984 Mar; 1(8376):528-30. PubMed ID: 6142252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytomegalovirus Vaccines: Current Status and Future Prospects.
    Anderholm KM; Bierle CJ; Schleiss MR
    Drugs; 2016 Nov; 76(17):1625-1645. PubMed ID: 27882457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector.
    Schleiss MR; Berka U; Watson E; Aistleithner M; Kiefmann B; Mangeat B; Swanson EC; Gillis PA; Hernandez-Alvarado N; Fernández-Alarcón C; Zabeli JC; Pinschewer DD; Lilja AE; Schwendinger M; Guirakhoo F; Monath TP; Orlinger KK
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27795301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.